Literature DB >> 30198808

LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature.

Uffe Ravnskov1, Michel de Lorgeril2, David M Diamond3,4, Rokuro Hama5, Tomohito Hamazaki6, Björn Hammarskjöld7, Niamh Hynes8, Malcolm Kendrick9, Peter H Langsjoen10, Luca Mascitelli11, Kilmer S McCully12, Harumi Okuyama13, Paul J Rosch14, Tore Schersten15,16, Sherif Sultan8, Ralf Sundberg17.   

Abstract

INTRODUCTION: For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated and that statin treatment, in particular when used as primary prevention, is of doubtful benefit. Areas covered: The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This article delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis. Expert commentary: Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.

Entities:  

Keywords:  Atherosclerosis; cardiovascular; cholesterol lowering; coronary heart disease; exposure–response; mortality; statin

Mesh:

Substances:

Year:  2018        PMID: 30198808     DOI: 10.1080/17512433.2018.1519391

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  27 in total

Review 1.  Translating the dose response into risk and benefit.

Authors:  John B Warren
Journal:  Br J Clin Pharmacol       Date:  2019-05-17       Impact factor: 4.335

2.  Synergistic Effect of Polydatin and Polygonatum sibiricum Polysaccharides in Combating Atherosclerosis via Suppressing TLR4-Mediated NF-κB Activation in ApoE-Deficient Mice.

Authors:  Genyi Ye; Yuhao Zhao; Junfeng Zhu; Zijian Zhang; Qiong Wang; Xu Jiang; Zhenxing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

3.  Metabolic Strategies in Healthcare: A New Era.

Authors:  Matthew Cl Phillips
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

4.  Do Not Treat Children with Statins.

Authors:  David M Diamond; Uffe Ravnskov; Michel de Lorgeril
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

5.  Associations of Genetic Variations in ABCA1 and Lifestyle Factors with Coronary Artery Disease in a Southern Chinese Population with Dyslipidemia: A Nested Case-Control Study.

Authors:  Tian-Yu Zhao; Song Lei; Liu Huang; Yi-Nan Wang; Xiao-Ni Wang; Ping-Pu Zhou; Xiao-Jun Xu; Long Zhang; Liang-Wen Xu; Lei Yang
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

6.  Formal comment on "Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease".

Authors:  David M Diamond; Michel de Lorgeril; Malcolm Kendrick; Uffe Ravnskov; Paul J Rosch
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

7.  Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.

Authors:  Yeonhee Lee; Sehoon Park; Soojin Lee; Yaerim Kim; Min Woo Kang; Semin Cho; Sanghyun Park; Kyungdo Han; Yong Chul Kim; Seoung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

8.  Is High Cholesterol Deleterious? An Alternative Point of View. Comment on Burén et al. A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial. Nutrients 2021, 13, 814.

Authors:  Uffe Ravnskov
Journal:  Nutrients       Date:  2021-06-21       Impact factor: 5.717

9.  Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.

Authors:  Matthew C L Phillips; Laura M Deprez; Grace M N Mortimer; Deborah K J Murtagh; Stacey McCoy; Ruth Mylchreest; Linda J Gilbertson; Karen M Clark; Patricia V Simpson; Eileen J McManus; Jee-Eun Oh; Satish Yadavaraj; Vanessa M King; Avinesh Pillai; Beatriz Romero-Ferrando; Martijn Brinkhuis; Bronwyn M Copeland; Shah Samad; Shenyang Liao; Jan A C Schepel
Journal:  Alzheimers Res Ther       Date:  2021-02-23       Impact factor: 6.982

10.  Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.

Authors:  Giampaolo Minetti
Journal:  Med Hypotheses       Date:  2020-07-21       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.